+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Boostrix"

DTP Vaccines Global Market Report 2024 - Product Thumbnail Image

DTP Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Pertussis Vaccine Global Market Report 2024 - Product Thumbnail Image

Pertussis Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Boostrix- Drug Insight, 2019 - Product Thumbnail Image

Boostrix- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Boostrix is a vaccine used to protect against diphtheria, tetanus, and pertussis (whooping cough). It is a combination of three antigens, which are proteins that stimulate the body's immune system to produce antibodies. Boostrix is typically administered as a single dose to adolescents aged 11-18 years old, and as a booster dose to adults aged 19-64 years old. It is also recommended for pregnant women in their third trimester. Boostrix is part of a larger market of vaccines, which are used to prevent and control the spread of infectious diseases. Vaccines work by introducing a weakened or killed form of a virus or bacteria into the body, which stimulates the body's immune system to produce antibodies that protect against future infection. The Boostrix market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Sanofi Pasteur, Merck & Co., Pfizer, and Novartis. Show Less Read more